Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 4, 2009-05 ,pp. : 437-456

Bentham Science Publishers

Access to resources Recommend Favorite

T-18, a stemonamide synthetic intermediate inhibits Pim kinase activity and induces cell apoptosis, acting as a potent anticancer drug

By                

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1245-1251

Spandidos Publications

Access to resources Recommend Favorite

Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy

By  

Current Cancer Therapy Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 117-126

Bentham Science Publishers

Access to resources Recommend Favorite

Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents

By Le Tourneau Christophe  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 65-72

Springer Publishing Company

Access to resources Recommend Favorite

Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 327-346

Bentham Science Publishers

Access to resources Recommend Favorite